A need for clear definitions and improved management for Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer in Asia-Pacific

被引：0
|
作者：
Lee, Lui Shiong
Kanesvaran, Ravindran
Kikuchi, Eiji
Nishiyama, Hiroshi
Ku, Ja Hyeon
Lin Tzu-Ping
Nishiyama, Hiroyuki
Ng, Chi Fai
Ng, Junice Yi Siu
Poon, Darren
Seo, Ho Kyung
Spiteri, Carmel
Tan, Ee Min
Tran, Ben
Tsai, Yuh-Shyan
机构：
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs2
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [41] Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Alam, Syed M.
    Larson, Matthew
    Srinivasan, Pugazhendhi
    Genz, Nick
    Fleer, Ryan
    Sardiu, Mihaela
    Thompson, Jeffrey
    Lee, Eugene
    Hamilton-Reeves, Jill
    Wulff-Burchfield, Elizabeth
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 431.e15 - 431.e20
  • [42] FAILURE OF BACILLUS CALMETTE-GUERIN THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: DEFINITION AND TREATMENT OPTIONS
    Gual Frau, Josep
    Palou, Joan
    Rodriguez, Oscar
    Parada, Ruben
    Breda, Alberto
    Villavicencio, Humberto
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (07): : 423 - 433
  • [43] Prognostic value of Bax expression in non-muscle invasive bladder cancer treated by Bacillus Calmette Guerin immunotherapy
    Ajili, F.
    Manai, M.
    Kacem, M.
    Tounssi, H.
    Darouiche, A.
    Chebil, M.
    Ennaifer, E.
    Boubaker, S.
    ALLERGY, 2012, 67 : 390 - 390
  • [44] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [45] Analysis of sex-based differences to Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Fadel, Jonathan
    Simonyan, David
    Fradet, Vincent
    Lodde, Michele
    Lacombe, Louis
    Fradet, Yves
    Toren, Paul
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (12) : 539.e1 - 539.e8
  • [46] Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
    Owen Alan Edwards Cooper
    Ola Ghatnekar
    Natalia Piglowska
    Charlie A. Smith
    Paul Swinburn
    James W. F. Catto
    Günter Niegisch
    Jørn Skibsted Jakobsen
    PharmacoEconomics - Open, 2023, 7 : 469 - 477
  • [47] Non-muscle invasive bladder cancer subtypes with differential response to intravesical bacillus Calmette-Guerin treatment
    De, Jong F. C.
    Laajala, T. D.
    Hoedemaeker, R. F.
    Rinaldetti, S.
    Jordan, K.
    Van der Made, A. C. J.
    Nieuwkamer, B.
    Boeve, E. R.
    Janssen, E. A. M.
    Mahmoudi, T.
    Boormans, J. L.
    Theodorescu, D.
    Costello, J. C.
    Zuiverloon, T. C. M.
    EUROPEAN UROLOGY, 2022, 81 : S105 - S106
  • [48] Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
    Cooper, Owen Alan Edwards
    Ghatnekar, Ola
    Piglowska, Natalia
    Smith, Charlie A.
    Swinburn, Paul
    Catto, James W. F.
    Niegisch, Guenter
    Jakobsen, Jorn Skibsted
    PHARMACOECONOMICS-OPEN, 2023, 7 (03) : 469 - 477
  • [49] Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer
    Obara, Wataru
    Hara, Isao
    Kato, Yoichiro
    Kato, Renpei
    Inoue, Keiji
    Sato, Fuminori
    Mimata, Hiromitsu
    Nakamura, Yusuke
    Fujioka, Tomoaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1371 - 1380
  • [50] Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
    Steinberg, Ryan L.
    Thomas, Lewis J.
    Mott, Sarah L.
    O'Donnell, Michael A.
    BLADDER CANCER, 2016, 2 (02) : 215 - 224
12345